Friday, March 15, 2019 2:52:27 PM
An even longer shot but a possibility nonetheless, is that we sue for the earlier shares where we had way over 50% of forum shares when this conflict of interest and bias conversion was happening. The odds are better than 10-1 in my opinion but still a gamble depending if the Canadian sec wants to help make an example out of pxp or not. And how the judge will look to see if these international trading laws were abused. Good luck to us all. This can make me or break me since I have close to 5 mil shares alone but I’m already looking at other ways to better my life since the odds are not greatly in our favor but I’m not selling regardless and hope to be pleasantly surprised. If you agree there was a conflict of interest as to how pxp handled everything then I suggest you hold your shares as well regardless of what the stock price says today or tomorrow. The outcome will soon be up to either a judge or a jury and if youve seen settlement stocks reactions to favorable judgments on small caps against big goliaths, you may see one of the biggest one day jumps in your life. I’m already betting on it by letting it ride. I’m just diversifying elsewhere like I always recommended people do from day one. I reserve the right to add a few 10000 shares here and there just to see the price get back up above 1 penny. It obviously doesn’t take much to move this stock . Overall- still high risk especially with this contract progress still in limbo when it should have been a done deal by now.
Recent FECOF News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/17/2023 04:38:59 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/17/2023 04:29:14 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM